NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 64,064 shares, an increase of 311.9% from the April 30th total of 15,554 shares. Currently, 38.1% of the company’s shares are short sold. Based on an average daily volume of 2,648,206 shares, the short-interest ratio is presently 0.0 days.

Insider Activity at NewGenIvf Group

In other NewGenIvf Group news, major shareholder Financial Lp Hrt purchased 137,541 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were bought at an average price of $0.99 per share, for a total transaction of $136,165.59. Following the completion of the acquisition, the insider owned 111,885 shares in the company, valued at approximately $110,766.15. This trade represents a -536.10% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 31.80% of the company’s stock.

NewGenIvf Group Trading Down 11.7%

NIVF stock opened at $0.91 on Friday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. NewGenIvf Group has a 12-month low of $0.72 and a 12-month high of $1,839.00. The company’s fifty day simple moving average is $1.65 and its 200 day simple moving average is $6.70.

NewGenIvf Group (NASDAQ:NIVF) last released its earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million for the quarter. As a group, research analysts predict that NewGenIvf Group will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.